Ashwagandha for Thyroid: What We Know and What We Don't

Ashwagandha is a popular Ayurvedic adaptogen marketed for stress and thyroid support. A single small randomized trial in subclinical hypothyroidism showed it lowered TSH and modestly raised T3 and T4 over eight weeks. But the evidence base is one study of 50 people, multiple case reports describe ashwagandha triggering thyrotoxicosis, and no major thyroid society recommends it.

Why ashwagandha keeps showing up in thyroid conversations

Ashwagandha (Withania somnifera) is one of the most prescribed herbs in Ayurveda. Western wellness culture imported it as an "adaptogen" — a plant supposedly able to help the body resist stress — and it has become a top-selling supplement [C2][C3]. The marketing claims usually include cortisol reduction, anxiety relief, sleep, and, increasingly, "thyroid support."

The thyroid claim is interesting because it isn't pure marketing — there is one real randomized trial behind it. The problem is what one trial of 50 people can and cannot prove, and what gets quietly left out of the wellness conversation.

The single trial behind the ashwagandha-thyroid claim

In 2018, Sharma and colleagues published a double-blind, placebo-controlled randomized trial of 50 adults with subclinical hypothyroidism (elevated TSH but normal T3 and T4) [C1]. Participants received either 600 mg/day of ashwagandha root extract (KSM-66) or matched placebo for 8 weeks. The ashwagandha group showed [C1]:

• TSH decreased significantly versus placebo
• Free T3 rose by approximately 41.5% versus 0.74% in placebo
• Free T4 rose by approximately 19.6% versus 1.9% in placebo
• No serious adverse events reported over the 8-week window

That is a real, statistically significant signal in a randomized design. It is also a small, short, single-site trial of an unusual patient population (subclinical hypothyroidism — not full Hashimoto's, not patients on levothyroxine). It has not been replicated in a larger trial. The 2022 review by Verma and colleagues noted that thyroid effects of ashwagandha need confirmation in larger, longer studies before clinical recommendations can change [C6].

Why the signal cuts both ways

If ashwagandha really does raise T3 and T4 — and the trial suggests it can — that is not automatically good news. Several real risks follow from the same mechanism.

Case reports of thyrotoxicosis. Multiple published case reports describe people developing thyrotoxicosis (high T3/T4, suppressed TSH, palpitations, weight loss, anxiety) after starting ashwagandha [C3][C6][C7]. In some, symptoms resolved only after stopping the supplement. The NIH LiverTox monograph flags ashwagandha-associated thyrotoxicosis and liver injury [C7].

Interaction with levothyroxine. If a patient is already on a dose of levothyroxine calibrated to normalize their TSH, adding a substance that further raises T3 and T4 can push them into iatrogenic hyperthyroidism — with atrial fibrillation, bone loss, and cardiovascular risk [C4]. The 2014 American Thyroid Association hypothyroidism guideline emphasizes that thyroid hormone levels should be monitored when any supplement that could affect absorption or action is started [C4].

Immune-modulating effects in Hashimoto's. Ashwagandha is described in laboratory studies as immunomodulatory, with effects on T-helper cell populations [C6]. Hashimoto's is an autoimmune disease driven by anti-thyroid immunity. There is no clinical trial of ashwagandha in Hashimoto's specifically, and no way to know whether stimulating immune pathways helps, hurts, or does nothing in someone whose immune system is already attacking the gland [C8].

Liver injury risk. The NIH LiverTox database lists ashwagandha as an established cause of clinically apparent acute liver injury, with cases reported worldwide [C7]. Most are mild and reversible after stopping, but severe cases including hepatic failure have been described [C7].

What the major thyroid bodies say about ashwagandha

The American Thyroid Association's patient-facing guidance does not recommend ashwagandha for hypothyroidism or Hashimoto's, and the 2014 ATA treatment guidelines do not include adaptogens among the evidence-based options for managing thyroid disease [C4]. The National Center for Complementary and Integrative Health (NCCIH) summary on ashwagandha notes possible short-term benefits for stress and anxiety but does not endorse it for thyroid conditions and flags the need for caution in people with autoimmune disease [C2].

In other words: one promising small trial, one consistent set of clinical society silence, and a non-zero list of harms in the literature.

Practical guidelines for thinking about ashwagandha and your thyroid

1. If you're already on levothyroxine, don't add ashwagandha without telling your endocrinologist. The 2018 trial suggests it can shift T3 and T4 upward — which can mean a dose that was correct yesterday is too high today [C1][C4].
2. If you have Hashimoto's, the safety case is weaker. No trial has tested ashwagandha in Hashimoto's specifically, and the immune-modulating profile makes outcomes unpredictable [C6][C8]. Most thyroid clinicians take a conservative position here.
3. Watch for thyrotoxicosis symptoms if you do try it. Racing heart, heat intolerance, weight loss, tremor, sleep disruption, or anxiety after starting are reasons to stop immediately and get TSH and free T4 checked [C3][C7].
4. Monitor liver enzymes if using long-term. The NIH LiverTox database lists ashwagandha as a documented cause of acute liver injury [C7]. A baseline and follow-up ALT/AST is a low-cost safety check.
5. Avoid in pregnancy and while breastfeeding. Multiple sources, including MSKCC and NCCIH, advise against use in pregnancy because of theoretical abortifacient effects and a lack of safety data [C2][C3].

Frequently asked questions

Does ashwagandha cure hypothyroidism? No. One 8-week trial in 50 patients with subclinical hypothyroidism showed lab shifts; no trial has shown long-term symptomatic improvement, cure, or reduction in the need for levothyroxine [C1][C6]. Hypothyroidism does not have a cure outside of treating underlying causes.

Is ashwagandha safe if I have Hashimoto's? The honest answer is we don't know. There are no randomized trials in Hashimoto's specifically, immune-modulating effects in lab studies cut in unpredictable directions for autoimmunity, and case reports of thyrotoxicosis exist [C6][C7][C8]. Most thyroid clinicians advise against it.

Can ashwagandha replace levothyroxine? No. The 2018 trial included 50 patients with mild subclinical hypothyroidism, not people with established disease who need replacement therapy. No randomized trial has shown ashwagandha can replace levothyroxine, and stopping prescribed thyroid medication is dangerous [C4].

What about ashwagandha for stress, not thyroid? This is a more defensible use. A 2019 randomized trial by Salve and colleagues found that 60 days of ashwagandha lowered self-reported stress and cortisol modestly versus placebo in healthy adults [C5]. The stress-and-sleep evidence is stronger than the thyroid evidence — but the liver and thyroid safety concerns still apply.

How would I know if it's affecting my thyroid? The reliable way is a TSH and free T4 test 6 to 8 weeks after starting [C4]. Symptoms like palpitations, anxiety, heat intolerance, or unintended weight loss in someone on levothyroxine should prompt an earlier lab check [C7].

Bottom line

Ashwagandha has one real trial behind its thyroid claim — 50 patients, subclinical hypothyroidism, eight weeks, lab improvements but no symptom data [C1]. It also has documented case reports of thyrotoxicosis and acute liver injury [C7], no clinical trial in Hashimoto's, and no endorsement from the American Thyroid Association or NCCIH [C2][C4]. If you are already on levothyroxine, do not add ashwagandha without informing your prescriber and rechecking labs. If you have Hashimoto's, the safety case is too thin to recommend it. For stress and sleep, the evidence is more defensible than for thyroid — but the same liver and thyroid risks still apply.

Sources

1. [C1] Sharma AK, Basu I, Singh S. Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients: A Double-Blind, Randomized Placebo-Controlled Trial. J Altern Complement Med. 2018;24(3):243–248. PubMed: 28829155
2. [C2] National Center for Complementary and Integrative Health. Ashwagandha — Health Information. nccih.nih.gov
3. [C3] Memorial Sloan Kettering Cancer Center, Integrative Medicine. Ashwagandha — About Herbs. mskcc.org
4. [C4] American Thyroid Association. Thyroid Hormone Treatment — Patient Information. thyroid.org
5. [C5] Salve J, Pate S, Debnath K, Langade D. Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-Blind, Randomized, Placebo-Controlled Clinical Study. Cureus. 2019;11(12):e6466. PubMed: 32021735
6. [C6] Verma N, Gupta SK, Tiwari S, Mishra AK. Safety of Ashwagandha Root Extract: A Randomized, Placebo-Controlled, Study in Healthy Volunteers. Complement Ther Med. 2022;68:102829. PubMed: 36118334
7. [C7] LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Ashwagandha. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases. ncbi.nlm.nih.gov/books/NBK548536
8. [C8] American Thyroid Association. Hashimoto's Thyroiditis — Patient Information. thyroid.org

---

For educational purposes only. Not medical advice. Always consult your healthcare provider.